BRCA2 and breast carcinoma: Previous researchers detected only 24 mitochondrial variants predicted to be deleterious by SIFT and probably damaging by PolyPhen2 in a cohort of 436 French Nationals with familial breast cancer but testing negative for BRCA1 and BRCA2 [57].